|
1
|
Ridge CA, Pua BB and Madoff DC:
Epidemiology and staging of renal cell carcinoma. Semin Intervent
Radiol. 31:3–8. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Ferlay J, Shin H-R, Bray F, Forman D,
Mathers C and Parkin DM: Estimates of worldwide burden of cancer in
2008: GLOBOCAN 2008. Int J Cancer. 127:2893–2917. 2010. View Article : Google Scholar
|
|
3
|
Natural Cancer Institute: Surveillance,
epidemiology, and end results program. SEER Stat Fact Sheets:
Kidney and renal pelvis cancer. http://seer.cancer.gov/statfacts/html/kidrp.html.
Accessed Jan 20, 2015.
|
|
4
|
Zhejiang Channel XNA: World kidney day:
Kidney cancer incidence increased year by year become 'invisible
killer'. http://www.zj.xinhuanet.com/newscenter/science/2014-03/13/c_119759340.htm.
Accessed March 13, 2014.
|
|
5
|
Chen W, Zheng R, Zhang S, Zhao P, Zeng H,
Zou X and He J: Annual report on status of cancer in China, 2010.
Chin J Cancer Res. 26:48–58. 2014.PubMed/NCBI
|
|
6
|
Motzer RJ, Bander NH and Nanus DM:
Renal-cell carcinoma. N Engl J Med. 335:865–875. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Sakamoto KM and Frank DA: CREB in the
pathophysiology of cancer: Implications for targeting transcription
factors for cancer therapy. Clin Cancer Res. 15:2583–2587. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Shankar DB, Cheng JC, Kinjo K, Federman N,
Moore TB, Gill A, Rao NP, Landaw EM and Sakamoto KM: The role of
CREB as a proto-oncogene in hematopoiesis and in acute myeloid
leukemia. Cancer Cell. 7:351–362. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Park JK, Park SH, So K, Bae IH, Yoo YD and
Um HD: ICAM-3 enhances the migratory and invasive potential of
human non-small cell lung cancer cells by inducing MMP-2 and MMP-9
via Akt and CREB. Int J Oncol. 36:181–192. 2010.
|
|
10
|
Zhang M, Xu JJ, Zhou RL and Zhang QY: cAMP
responsive element binding protein-1 is a transcription factor of
lysosomal-associated protein transmembrane-4 Beta in human breast
cancer cells. PLoS One. 8:e575202013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Perry C, Sklan EH and Soreq H: CREB
regulates AChE-R-induced proliferation of human glioblastoma cells.
Neoplasia. 6:279–286. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Shukla A, Bosenberg MW, MacPherson MB,
Butnor KJ, Heintz NH, Pass HI, Carbone M, Testa JR and Mossman BT:
Activated cAMP response element binding protein is overexpressed in
human mesotheliomas and inhibits apoptosis. Am J Pathol.
175:2197–2206. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Horvath A, Boikos S, Giatzakis C,
Robinson-White A, Groussin L, Griffin KJ, Stein E, Levine E,
Delimpasi G, Hsiao HP, et al: A genome-wide scan identifies
mutations in the gene encoding phosphodiesterase 11A4 (PDE11A) in
individuals with adrenocortical hyperplasia. Nat Genet. 38:794–800.
2006. View
Article : Google Scholar : PubMed/NCBI
|
|
14
|
Coxon A, Rozenblum E, Park YS, Joshi N,
Tsurutani J, Dennis PA, Kirsch IR and Kaye FJ: Mect1-Maml2 fusion
oncogene linked to the aberrant activation of cyclic AMP/CREB
regulated genes. Cancer Res. 65:7137–7144. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Siu YT and Jin DY: CREB - a real culprit
in oncogenesis. FEBS J. 274:3224–3232. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ahn S, Olive M, Aggarwal S, Krylov D,
Ginty DD and Vinson C: A dominant-negative inhibitor of CREB
reveals that it is a general mediator of stimulus-dependent
transcription of c-fos. Mol Cell Biol. 18:967–977. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Desdouets C, Matesic G, Molina CA, Foulkes
NS, Sassone-Corsi P, Brechot C and Sobczak-Thepot J: Cell cycle
regulation of cyclin A gene expression by the cyclic AMP-responsive
transcription factors CREB and CREM. Mol Cell Biol. 15:3301–3309.
1995. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
White PC, Shore AM, Clement M, McLaren J,
Soeiro I, Lam EW and Brennan P: Regulation of cyclin D2 and the
cyclin D2 promoter by protein kinase A and CREB in lymphocytes.
Oncogene. 25:2170–2180. 2006. View Article : Google Scholar
|
|
19
|
Mayr B and Montminy M: Transcriptional
regulation by the phosphorylation-dependent factor CREB. Nat Rev
Mol Cell Biol. 2:599–609. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Impey S, McCorkle SR, Cha-Molstad H, Dwyer
JM, Yochum GS, Boss JM, McWeeney S, Dunn JJ, Mandel G and Goodman
RH: Defining the CREB regulon: A genome-wide analysis of
transcription factor regulatory regions. Cell. 119:1041–1054.
2004.PubMed/NCBI
|
|
21
|
Zhang X, Odom DT, Koo SH, Conkright MD,
Canettieri G, Best J, Chen H, Jenner R, Herbolsheimer E, Jacobsen
E, et al: Genome-wide analysis of cAMP-response element binding
protein occupancy, phosphorylation, and target gene activation in
human tissues. Proc Natl Acad Sci USA. 102:4459–4464. 2005.
View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Krol J, Loedige I and Filipowicz W: The
widespread regulation of microRNA biogenesis, function and decay.
Nat Rev Genet. 11:597–610. 2010.PubMed/NCBI
|
|
23
|
Bartel DP: MicroRNAs: Target recognition
and regulatory functions. Cell. 136:215–233. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Carthew RW and Sontheimer EJ: Origins and
mechanisms of miRNAs and siRNAs. Cell. 136:642–655. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Huntzinger E and Izaurralde E: Gene
silencing by microRNAs: Contributions of translational repression
and mRNA decay. Nat Rev Genet. 12:99–110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Maher ER: Genomics and epigenomics of
renal cell carcinoma. Semin Cancer Biol. 23:10–17. 2013. View Article : Google Scholar
|
|
27
|
Chow TF, Mankaruos M, Scorilas A, Youssef
Y, Girgis A, Mossad S, Metias S, Rofael Y, Honey RJ, Stewart R, et
al: The miR-17-92 cluster is over expressed in and has an oncogenic
effect on renal cell carcinoma. J Urol. 183:743–751. 2010.
View Article : Google Scholar
|
|
28
|
Müller S and Nowak K: Exploring the
miRNA-mRNA regulatory network in clear cell renal cell carcinomas
by next-generation sequencing expression profiles. BioMed Res Int.
2014:9484082014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Liu H, Brannon AR, Reddy AR, Alexe G,
Seiler MW, Arreola A, Oza JH, Yao M, Juan D, Liou LS, et al:
Identifying mRNA targets of microRNA dysregulated in cancer: With
application to clear cell renal cell carcinoma. BMC Syst Biol.
4:512010. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Juan D, Alexe G, Antes T, Liu H,
Madabhushi A, Delisi C, Ganesan S, Bhanot G and Liou LS:
Identification of a microRNA panel for clear-cell kidney cancer.
Urology. 75:835–841. 2010. View Article : Google Scholar
|
|
31
|
Yi Z, Fu Y, Zhao S, Zhang X and Ma C:
Differential expression of miRNA patterns in renal cell carcinoma
and nontumorous tissues. J Cancer Res Clin Oncol. 136:855–862.
2010. View Article : Google Scholar
|
|
32
|
White NM, Khella HW, Grigull J, Adzovic S,
Youssef YM, Honey RJ, Stewart R, Pace KT, Bjarnason GA, Jewett MA,
et al: miRNA profiling in metastatic renal cell carcinoma reveals a
tumour-suppressor effect for miR-215. Br J Cancer. 105:1741–1749.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Wu X, Weng L, Li X, Guo C, Pal SK, Jin JM,
Li Y, Nelson RA, Mu B, Onami SH, et al: Identification of a
4-microRNA signature for clear cell renal cell carcinoma metastasis
and prognosis. PLoS One. 7:e356612012. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Taylor AK, Klisak I, Mohandas T, Sparkes
RS, Li C, Gaynor R and Lusis AJ: Assignment of the human gene for
CREB1 to chromosome 2q32.3–q34. Genomics. 7:416–421. 1990.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Janz S: Myc translocations in B cell and
plasma cell neoplasms. DNA Repair (Amst). 5:1213–1224. 2006.
View Article : Google Scholar
|
|
36
|
Tan X, Wang S, Zhu L, Wu C, Yin B, Zhao J,
Yuan J, Qiang B and Peng X: cAMP response element-binding protein
promotes gliomagenesis by modulating the expression of oncogenic
microRNA-23a. Proc Natl Acad Sci USA. 109:15805–15810. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Antonescu CR, Nafa K, Segal NH, Dal Cin P
and Ladanyi M: EWS-CREB1: A recurrent variant fusion in clear cell
sarcoma - association with gastrointestinal location and absence of
melanocytic differentiation. Clin Cancer Res. 12:5356–5362. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Hallor KH, Micci F, Meis-Kindblom JM,
Kindblom LG, Bacchini P, Mandahl N, Mertens F and Panagopoulos I:
Fusion genes in angiomatoid fibrous histiocytoma. Cancer Lett.
251:158–163. 2007. View Article : Google Scholar
|
|
39
|
Tonon G, Modi S, Wu L, Kubo A, Coxon AB,
Komiya T, O'Neil K, Stover K, El-Naggar A, Griffin JD, et al:
t(11;19) (q21; p13) translocation in mucoepidermoid carcinoma
creates a novel fusion product that disrupts a Notch signaling
pathway. Nat Genet. 33:208–213. 2003. View
Article : Google Scholar : PubMed/NCBI
|
|
40
|
Kwok RP, Laurance ME, Lundblad JR, Goldman
PS, Shih H, Connor LM, Marriott SJ and Goodman RH: Control of
cAMP-regulated enhancers by the viral transactivator Tax through
CREB and the co-activator CBP. Nature. 380:642–646. 1996.
View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Baranger AM, Palmer CR, Hamm MK, Giebler
HA, Brauweiler A, Nyborg JK and Schepartz A: Mechanism of
DNA-binding enhancement by the human T-cell leukaemia virus
transactivator Tax. Nature. 376:606–608. 1995. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Maguire HF, Hoeffler JP and Siddiqui A:
HBV X protein alters the DNA binding specificity of CREB and ATF-2
by protein-protein interactions. Science. 252:842–844. 1991.
View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Barnabas S, Hai T and Andrisani OM: The
hepatitis B virus X protein enhances the DNA binding potential and
transcription efficacy of bZip transcription factors. J Biol Chem.
272:20684–20690. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Katoh Y, Takemori H, Lin XZ, Tamura M,
Muraoka M, Satoh T, Tsuchiya Y, Min L, Doi J, Miyauchi A, et al:
Silencing the constitutive active transcription factor CREB by the
LKB1-SIK signaling cascade. FEBS J. 273:2730–2748. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Chen L, Yang Q, Kong WQ, Liu T, Liu M, Li
X and Tang H: MicroRNA-181b targets cAMP responsive element binding
protein 1 in gastric adenocarcinomas. IUBMB Life. 64:628–635. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Kong WQ, Bai R, Liu T, Cai CL, Liu M, Li X
and Tang H: MicroRNA-182 targets cAMP-responsive element-binding
protein 1 and suppresses cell growth in human gastric
adenocarcinoma. FEBS J. 279:1252–1260. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Peng B, Hu S, Jun Q, Luo D, Zhang X, Zhao
H and Li D: MicroRNA-200b targets CREB1 and suppresses cell growth
in human malignant glioma. Mol Cell Biochem. 379:51–58. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pigazzi M, Manara E, Bresolin S, Tregnago
C, Beghin A, Baron E, Giarin E, Cho EC, Masetti R, Rao DS, et al:
MicroRNA-34b promoter hypermethylation induces CREB overexpression
and contributes to myeloid transformation. Haematologica.
98:602–610. 2013. View Article : Google Scholar :
|
|
49
|
Yang Z, Tsuchiya H, Zhang Y, Hartnett ME
and Wang L: MicroRNA-433 inhibits liver cancer cell migration by
repressing the protein expression and function of cAMP response
element-binding protein. J Biol Chem. 288:28893–28899. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Qian J, Li R, Wang YY, Shi Y, Luan WK, Tao
T, Zhang JX, Xu YC and You YP: miR-1224-5p acts as a tumor
suppressor by targeting CREB1 in malignant gliomas. Mol Cell
Biochem. 403:33–41. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Tan X, Wang S, Yang B, Zhu L, Yin B, Chao
T, Zhao J, Yuan J, Qiang B and Peng X: The CREB-miR-9 negative
feedback minicircuitry coordinates the migration and proliferation
of glioma cells. PLoS One. 7:e495702012. View Article : Google Scholar : PubMed/NCBI
|
|
52
|
Pigazzi M, Manara E, Baron E and Basso G:
miR-34b targets cyclic AMP-responsive element binding protein in
acute myeloid leukemia. Cancer Res. 69:2471–2478. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Heinzelmann J, Henning B, Sanjmyatav J,
Posorski N, Steiner T, Wunderlich H, Gajda MR and Junker K:
Specific miRNA signatures are associated with metastasis and poor
prognosis in clear cell renal cell carcinoma. World J Urol.
29:367–373. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Slaby O, Redova M, Poprach A, Nekvindova
J, Iliev R, Radova L, Lakomy R, Svoboda M and Vyzula R:
Identification of microRNAs associated with early relapse after
nephrectomy in renal cell carcinoma patients. Genes Chromosomes
Cancer. 51:707–716. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
55
|
Li M, Guan X, Sun Y, Mi J, Shu X, Liu F
and Li C: miR-92a family and their target genes in tumorigenesis
and metastasis. Exp Cell Res. 323:1–6. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Sun Q, Zhang J, Cao W, Wang X, Xu Q, Yan
M, Wu X and Chen W: Dysregulated miR-363 affects head and neck
cancer invasion and metastasis by targeting podoplanin. Int J
Biochem Cell Biol. 45:513–520. 2013. View Article : Google Scholar
|
|
57
|
Han H, Sun D, Li W, Shen H, Zhu Y, Li C,
Chen Y, Lu L, Li W, Zhang J, et al: A c-Myc-microRNA functional
feedback loop affects hepatocarcinogenesis. Hepatology.
57:2378–2389. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
58
|
Zhou P, Huang G, Zhao Y, Zhong D, Xu Z,
Zeng Y, Zhang Y, Li S and He F: MicroRNA-363-mediated
downregulation of S1PR1 suppresses the proliferation of
hepatocellular carcinoma cells. Cell Signal. 26:1347–1354. 2014.
View Article : Google Scholar : PubMed/NCBI
|
